Based on MarketsandMarkets™ report "Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) - Global Forecast to 2027", projected to reach USD 7.7 billion by 2027 from USD 5.0 billion in 2022, at a CAGR of 8.7% during the forecast period. Factors such as increasing incidence of cardiovascular diseases, increasing demand for early diagnois od cardiacovascular diseases, growing public-private investments to support for the clinical research of novel cardiac biomarkers, and risng geriatric patient population are anticiapted to fuel the growth of the market during the forecast period.

Download PDF Brochure :
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64885447

Browse
• 138 Market data Tables
• 46 Figures
• 210 Pages and in-depth TOC on "Cardiac Marker Testing Market - Global Forecast to 2027"

Some of the prominent key players are:
F. Hoffmann-La Roche AG (Switzerland),
Abbott Laboratories (US),
Danaher Corporation (US),
Siemens Healthineers AG (Germany),
PerkinElmer, Inc. (US),
bioMérieux SA (France),
Becton, Dickinson and Company (US), and many more.......
Request For Customization:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=64885447

Based on products , kits and reagent segment accounted for the largest share of the cardiac marjer tetsing market in 2021.

On the basis of product , the cardiac marker testing market is segmented into kit & reagaents and Instruments. In 2021, the kit & reagaents segment accounted for the largest share of the cardiac marker testing market. Rising prevalence of cardiovascuoar diseases and increasing demand for rapid diagnosis of heart conditions have enhanced the usage of reagents and kits in diagnostic laboratories, academic institutes, and POC facilities. Moreover, rising volume of cardiac marker testing procedures and increase availability of different cardiac biomarker kits and reagents are contrinuting towards the largest share of the segment.

Based on biomarker type , Troponin I and T segment accounted for the largest share of the cardiac marker testing market in 2021.

Due to the high senitivity and specificity are marking troponin choice of biomarker among lab professionsl for the dection of cardiac injury. Moreover, the growing focus of players in introducing higher senistitvity troponin with capabililty of detection of lower level of concenttation of troponin in blood samples are expected to support the growth of the segment.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=64885447

North America to command the largest share of the cardiac marker testing market in 2021

Based on region, the cardiac marker testing market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa North America accounted for the largest share of the cardiac marker testing market in 2021. The growth of the North American market is primarily driven by the increasing geriatric population, high incidence/prevalence of cardiovascular diseases, increasing number of cardiac marker testing procedures, and strong foothold of well-estanlished players with strong cardiac biomarker testing product portfolio. Moreover, the rising support from the government to support the discovery of new cardiac biomarker is likely to boost the cardiac marker testing market in North America.
About MaketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.